Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Treatment with interferon beta for multiple sclerosis.
The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions.
Subject movement during multislice interleaved MR acquisitions: Prevalence and potential effect on MRI-derived brain pathology measurements and multicenter clinical trials of therapeutics for multiple sclerosis.
Neurons and T cells: Understanding this interaction for inflammatory neurological diseases.
Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects.
Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.
Simvastatin interferes with process outgrowth and branching of oligodendrocytes.
No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients.
Case report: an orofacial pain patient with spots on the brain-multiple sclerosis versus central systemic lupus erythematosus.
Expression of vitamin d receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
Riboflavin Supplementation to Patients with Multiple Sclerosis does not Improve Disability Status nor is Riboflavin Supplementation Correlated to Homocysteine.
Human Umbilical Cord Mesenchymal Stem Cell Therapy on Neuromyelitis Optica.
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.
Neurodegeneration in multiple sclerosis is a process separate from inflammation: Yes.
Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis.
Treatment of Acute Relapses in Multiple Sclerosis.
MRI unsampling using feature-based non-local means approach.
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.
Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis.
Structural and Metabolic Features of Two Different Variants of Multiple Sclerosis: A PET/MRI Study.
Prolactin Is Not Required for the Development of Severe Chronic Experimental Autoimmune Encephalomyelitis.
Age and the role of restricted activities in adjustment to disability related pain.
Neural correlates of alerting and orienting impairment in multiple sclerosis patients.
Alemtuzumab for relapsing-remitting multiple sclerosis.

Pages